nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—Tongue coated—Varenicline—nicotine dependence	0.103	0.103	CcSEcCtD
Metronidazole—Myopia—Varenicline—nicotine dependence	0.0636	0.0639	CcSEcCtD
Metronidazole—Depressed mood—Varenicline—nicotine dependence	0.031	0.0312	CcSEcCtD
Metronidazole—Urine abnormality—Varenicline—nicotine dependence	0.0251	0.0252	CcSEcCtD
Metronidazole—Urine analysis abnormal—Varenicline—nicotine dependence	0.0236	0.0237	CcSEcCtD
Metronidazole—Vaginal discharge—Varenicline—nicotine dependence	0.0228	0.0229	CcSEcCtD
Metronidazole—Nystagmus—Varenicline—nicotine dependence	0.0194	0.0195	CcSEcCtD
Metronidazole—Menorrhagia—Varenicline—nicotine dependence	0.0188	0.0188	CcSEcCtD
Metronidazole—Fungal infection—Varenicline—nicotine dependence	0.018	0.0181	CcSEcCtD
Metronidazole—Gingivitis—Varenicline—nicotine dependence	0.0177	0.0178	CcSEcCtD
Metronidazole—Eye irritation—Varenicline—nicotine dependence	0.0163	0.0163	CcSEcCtD
Metronidazole—Lacrimation increased—Varenicline—nicotine dependence	0.0151	0.0151	CcSEcCtD
Metronidazole—Dysarthria—Varenicline—nicotine dependence	0.0147	0.0147	CcSEcCtD
Metronidazole—Coordination abnormal—Varenicline—nicotine dependence	0.0141	0.0142	CcSEcCtD
Metronidazole—Eructation—Varenicline—nicotine dependence	0.0136	0.0137	CcSEcCtD
Metronidazole—Influenza like illness—Varenicline—nicotine dependence	0.0135	0.0135	CcSEcCtD
Metronidazole—Urine output increased—Varenicline—nicotine dependence	0.0125	0.0126	CcSEcCtD
Metronidazole—Polyuria—Varenicline—nicotine dependence	0.0115	0.0115	CcSEcCtD
Metronidazole—Disorientation—Varenicline—nicotine dependence	0.0113	0.0113	CcSEcCtD
Metronidazole—Libido decreased—Varenicline—nicotine dependence	0.0109	0.0109	CcSEcCtD
Metronidazole—Osteoarthritis—Varenicline—nicotine dependence	0.0101	0.0101	CcSEcCtD
Metronidazole—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.01	0.01	CcSEcCtD
Metronidazole—Psychotic disorder—Varenicline—nicotine dependence	0.00984	0.00989	CcSEcCtD
Metronidazole—Irritability—Varenicline—nicotine dependence	0.00962	0.00966	CcSEcCtD
Metronidazole—Liver function test abnormal—Varenicline—nicotine dependence	0.0093	0.00935	CcSEcCtD
Metronidazole—Dry skin—Varenicline—nicotine dependence	0.00923	0.00928	CcSEcCtD
Metronidazole—Abdominal pain upper—Varenicline—nicotine dependence	0.0092	0.00925	CcSEcCtD
Metronidazole—Breast disorder—Varenicline—nicotine dependence	0.0091	0.00915	CcSEcCtD
Metronidazole—Cramp muscle—Varenicline—nicotine dependence	0.00907	0.00912	CcSEcCtD
Metronidazole—Nasopharyngitis—Varenicline—nicotine dependence	0.00901	0.00905	CcSEcCtD
Metronidazole—Abdominal distension—Varenicline—nicotine dependence	0.00877	0.00881	CcSEcCtD
Metronidazole—Asthma—Varenicline—nicotine dependence	0.00871	0.00875	CcSEcCtD
Metronidazole—Bronchitis—Varenicline—nicotine dependence	0.00837	0.00841	CcSEcCtD
Metronidazole—Abdominal discomfort—Varenicline—nicotine dependence	0.00835	0.00839	CcSEcCtD
Metronidazole—Pollakiuria—Varenicline—nicotine dependence	0.00804	0.00808	CcSEcCtD
Metronidazole—Photosensitivity reaction—Varenicline—nicotine dependence	0.00795	0.00799	CcSEcCtD
Metronidazole—Infestation NOS—Varenicline—nicotine dependence	0.00776	0.0078	CcSEcCtD
Metronidazole—Infestation—Varenicline—nicotine dependence	0.00776	0.0078	CcSEcCtD
Metronidazole—Depression—Varenicline—nicotine dependence	0.00774	0.00778	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.0077	0.00773	CcSEcCtD
Metronidazole—Stomatitis—Varenicline—nicotine dependence	0.00757	0.0076	CcSEcCtD
Metronidazole—Conjunctivitis—Varenicline—nicotine dependence	0.00755	0.00758	CcSEcCtD
Metronidazole—Hepatobiliary disease—Varenicline—nicotine dependence	0.00734	0.00738	CcSEcCtD
Metronidazole—Sinusitis—Varenicline—nicotine dependence	0.00728	0.00732	CcSEcCtD
Metronidazole—Hallucination—Varenicline—nicotine dependence	0.00693	0.00697	CcSEcCtD
Metronidazole—Hypoaesthesia—Varenicline—nicotine dependence	0.00693	0.00697	CcSEcCtD
Metronidazole—Connective tissue disorder—Varenicline—nicotine dependence	0.00685	0.00688	CcSEcCtD
Metronidazole—Visual impairment—Varenicline—nicotine dependence	0.00672	0.00675	CcSEcCtD
Metronidazole—Erythema multiforme—Varenicline—nicotine dependence	0.00659	0.00662	CcSEcCtD
Metronidazole—Eye disorder—Varenicline—nicotine dependence	0.00651	0.00654	CcSEcCtD
Metronidazole—Tinnitus—Varenicline—nicotine dependence	0.0065	0.00653	CcSEcCtD
Metronidazole—Cardiac disorder—Varenicline—nicotine dependence	0.00647	0.0065	CcSEcCtD
Metronidazole—Angiopathy—Varenicline—nicotine dependence	0.00632	0.00635	CcSEcCtD
Metronidazole—Immune system disorder—Varenicline—nicotine dependence	0.0063	0.00633	CcSEcCtD
Metronidazole—Mediastinal disorder—Varenicline—nicotine dependence	0.00628	0.00631	CcSEcCtD
Metronidazole—Mental disorder—Varenicline—nicotine dependence	0.00611	0.00614	CcSEcCtD
Metronidazole—Erythema—Varenicline—nicotine dependence	0.00607	0.0061	CcSEcCtD
Metronidazole—Flatulence—Varenicline—nicotine dependence	0.00598	0.00601	CcSEcCtD
Metronidazole—Dysgeusia—Varenicline—nicotine dependence	0.00594	0.00597	CcSEcCtD
Metronidazole—Back pain—Varenicline—nicotine dependence	0.00587	0.0059	CcSEcCtD
Metronidazole—Muscle spasms—Varenicline—nicotine dependence	0.00583	0.00586	CcSEcCtD
Metronidazole—Vision blurred—Varenicline—nicotine dependence	0.00572	0.00575	CcSEcCtD
Metronidazole—Tremor—Varenicline—nicotine dependence	0.00568	0.00571	CcSEcCtD
Metronidazole—Angioedema—Varenicline—nicotine dependence	0.00554	0.00557	CcSEcCtD
Metronidazole—Malaise—Varenicline—nicotine dependence	0.00547	0.0055	CcSEcCtD
Metronidazole—Vertigo—Varenicline—nicotine dependence	0.00545	0.00548	CcSEcCtD
Metronidazole—Syncope—Varenicline—nicotine dependence	0.00544	0.00547	CcSEcCtD
Metronidazole—Palpitations—Varenicline—nicotine dependence	0.00536	0.00539	CcSEcCtD
Metronidazole—Loss of consciousness—Varenicline—nicotine dependence	0.00533	0.00536	CcSEcCtD
Metronidazole—Convulsion—Varenicline—nicotine dependence	0.00526	0.00528	CcSEcCtD
Metronidazole—Hypertension—Varenicline—nicotine dependence	0.00524	0.00526	CcSEcCtD
Metronidazole—Arthralgia—Varenicline—nicotine dependence	0.00517	0.00519	CcSEcCtD
Metronidazole—Chest pain—Varenicline—nicotine dependence	0.00517	0.00519	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00513	0.00515	CcSEcCtD
Metronidazole—Dry mouth—Varenicline—nicotine dependence	0.00505	0.00508	CcSEcCtD
Metronidazole—Oedema—Varenicline—nicotine dependence	0.00495	0.00498	CcSEcCtD
Metronidazole—Infection—Varenicline—nicotine dependence	0.00492	0.00494	CcSEcCtD
Metronidazole—Shock—Varenicline—nicotine dependence	0.00487	0.00489	CcSEcCtD
Metronidazole—Nervous system disorder—Varenicline—nicotine dependence	0.00486	0.00488	CcSEcCtD
Metronidazole—Thrombocytopenia—Varenicline—nicotine dependence	0.00485	0.00487	CcSEcCtD
Metronidazole—Skin disorder—Varenicline—nicotine dependence	0.00481	0.00483	CcSEcCtD
Metronidazole—Hyperhidrosis—Varenicline—nicotine dependence	0.00479	0.00481	CcSEcCtD
Metronidazole—Anorexia—Varenicline—nicotine dependence	0.00472	0.00474	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00451	0.00453	CcSEcCtD
Metronidazole—Insomnia—Varenicline—nicotine dependence	0.00448	0.0045	CcSEcCtD
Metronidazole—Somnolence—Varenicline—nicotine dependence	0.0044	0.00442	CcSEcCtD
Metronidazole—Dyspepsia—Varenicline—nicotine dependence	0.00436	0.00438	CcSEcCtD
Metronidazole—Decreased appetite—Varenicline—nicotine dependence	0.0043	0.00433	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00428	0.0043	CcSEcCtD
Metronidazole—Fatigue—Varenicline—nicotine dependence	0.00427	0.00429	CcSEcCtD
Metronidazole—Pain—Varenicline—nicotine dependence	0.00423	0.00425	CcSEcCtD
Metronidazole—Constipation—Varenicline—nicotine dependence	0.00423	0.00425	CcSEcCtD
Metronidazole—Feeling abnormal—Varenicline—nicotine dependence	0.00408	0.0041	CcSEcCtD
Metronidazole—Gastrointestinal pain—Varenicline—nicotine dependence	0.00405	0.00407	CcSEcCtD
Metronidazole—Urticaria—Varenicline—nicotine dependence	0.00393	0.00395	CcSEcCtD
Metronidazole—Body temperature increased—Varenicline—nicotine dependence	0.00391	0.00393	CcSEcCtD
Metronidazole—Abdominal pain—Varenicline—nicotine dependence	0.00391	0.00393	CcSEcCtD
Metronidazole—Hypersensitivity—Varenicline—nicotine dependence	0.00365	0.00367	CcSEcCtD
Metronidazole—Asthenia—Varenicline—nicotine dependence	0.00355	0.00357	CcSEcCtD
Metronidazole—Pruritus—Varenicline—nicotine dependence	0.0035	0.00352	CcSEcCtD
Metronidazole—Diarrhoea—Varenicline—nicotine dependence	0.00339	0.0034	CcSEcCtD
Metronidazole—Dizziness—Varenicline—nicotine dependence	0.00327	0.00329	CcSEcCtD
Metronidazole—Vomiting—Varenicline—nicotine dependence	0.00315	0.00316	CcSEcCtD
Metronidazole—Rash—Varenicline—nicotine dependence	0.00312	0.00314	CcSEcCtD
Metronidazole—Dermatitis—Varenicline—nicotine dependence	0.00312	0.00313	CcSEcCtD
Metronidazole—Headache—Varenicline—nicotine dependence	0.0031	0.00312	CcSEcCtD
Metronidazole—Nausea—Varenicline—nicotine dependence	0.00294	0.00296	CcSEcCtD
Metronidazole—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.000817	0.172	CbGpPWpGaD
Metronidazole—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.000665	0.14	CbGpPWpGaD
Metronidazole—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.000506	0.107	CbGpPWpGaD
Metronidazole—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.000412	0.087	CbGpPWpGaD
Metronidazole—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.000272	0.0574	CbGpPWpGaD
Metronidazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00021	0.0444	CbGpPWpGaD
Metronidazole—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000207	0.0438	CbGpPWpGaD
Metronidazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000171	0.0361	CbGpPWpGaD
Metronidazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00017	0.036	CbGpPWpGaD
Metronidazole—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000169	0.0356	CbGpPWpGaD
Metronidazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000139	0.0293	CbGpPWpGaD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000113	0.0238	CbGpPWpGaD
Metronidazole—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000111	0.0235	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	9.6e-05	0.0203	CbGpPWpGaD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	9.14e-05	0.0193	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	9.05e-05	0.0191	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	8.93e-05	0.0188	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	7.81e-05	0.0165	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	7.37e-05	0.0155	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	7.26e-05	0.0153	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	5.15e-05	0.0109	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	4.86e-05	0.0103	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	4.79e-05	0.0101	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP2A7—nicotine dependence	1.55e-05	0.00327	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP2A7—nicotine dependence	1.26e-05	0.00266	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP2A7—nicotine dependence	8.31e-06	0.00175	CbGpPWpGaD
